Literature DB >> 28489138

Attention-deficit/hyperactivity disorder: the impact of methylphenidate on working memory, inhibition capacity and mental flexibility.

Cristiana Bolfer1, Sandra Pasquali Pacheco2, Miriam Harumi Tsunemi3, Walter Souza Carreira4, Beatriz Borba Casella5, Erasmo Barbante Casella1,6.   

Abstract

OBJECTIVE: To compare children with attention-deficit/hyperactivity disorder (ADHD), before and after the use of methylphenidate, and a control group, using tests of working memory, inhibition capacity and mental flexibility.
METHODS: Neuropsychological tests were administrated to 53 boys, 9-12 years old: the WISC-III digit span backward, and arithmetic; Stroop Color; and Trail Making Tests. The case group included 23 boys with ADHD, who were combined type, treatment-naive, and with normal intelligence without comorbidities. The control group (n = 30) were age and gender matched. After three months on methylphenidate, the ADHD children were retested. The control group was also retested after three months.
RESULTS: Before treatment, ADHD children had lower scores than the control group on the tests (p ≤ 0.001) and after methylphenidate had fewer test errors than before (p ≤ 0.001).
CONCLUSION: Methylphenidate treatment improves the working memory, inhibitory control and mental flexibility of ADHD boys.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28489138     DOI: 10.1590/0004-282X20170030

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study.

Authors:  Paul T Rosenau; Thaïra J C Openneer; Anne-Flore M Matthijssen; Gigi H H van de Loo-Neus; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra; Andrea Dietrich
Journal:  J Child Psychol Psychiatry       Date:  2021-03-28       Impact factor: 8.265

2.  Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.

Authors:  Ann-Marie Low; Julijana le Sommer; Signe Vangkilde; Birgitte Fagerlund; Birte Glenthøj; Edmund Sonuga-Barke; Thomas Habekost; Jens Richardt Møllegaard Jepsen
Journal:  Int J Neuropsychopharmacol       Date:  2018-11-01       Impact factor: 5.176

3.  Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer's Disease.

Authors:  Nishat Malik; Sanila Amber; Saadia Zahid
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.